Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults With Chronic Plaque Psoriasis From a 52-Week, Phase 2 Open-Label Safety Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 4, p. s218, 2023. DOI: 10.25251/skin.7.supp.218. Disponível em: https://skin.dermsquared.com/skin/article/view/2194. Acesso em: 18 apr. 2025.